跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TENOFOVIR EMT LAPL tenofovir disoproxil phosphate and emtricitabine 291mg/200mg film coated tablets - TGA Drug Approval Details
Approvals
/
TGA
/
TENOFOVIR EMT LAPL tenofovir disoproxil phosphate and emtricitabine 291mg/200mg film coated tablets
Approved
STANDARD
TENOFOVIR EMT LAPL tenofovir disoproxil phosphate and emtricitabine 291mg/200mg film coated tablets
Lupin Australia Pty Limited
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
a45012debc7a8495
Company
Lupin Australia Pty Limited
Type
Standard
Approval Details
Approval Id
a45012debc7a8495
Product Name
TENOFOVIR EMT LAPL tenofovir disoproxil phosphate and emtricitabine 291mg/200mg film coated tablets
Artg Id
269197
Artg Name
TENOFOVIR EMT LAPL tenofovir disoproxil phosphate and emtricitabine 291mg/200mg film coated tablets
Sponsor
Lupin Australia Pty Limited
Company Detail Path
/organization/lupin-australia-pty-limited
Artg Date
2017-01-31
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
a45012debc7a8495
Type
Standard
Back to TGA Approvals
